Biocon's stock rose by 1.54% to reach ₹260.55 following the announcement of approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K., for its complex formulation Liraglutide.
Dr Reddy's Laboratories' shares gained as much as 3% in the afternoon session on March 28 after the business announced an exclusive alliance with Sanofi Healthcare India Private Limited (SHIPL). At ...
Alkem Laboratories witnessed a 3% decline in its shares during early trading on March 28 following the issuance of a Form 483 with 10 observations by the US Food and Drug Administration (FDA) for its ...
Cyient's stock surged by 2% in early trading on March 28 following its partnership announcement with a German original equipment manufacturer (OEM). At the time of reporting, Cyient was trading at ...
SRM Contractors IPO witnessed significant interest from retail and non-institutional investors (NIIs) on both days of its offering period, which began on March 26 and ends on March 28. On the third ...
The US dollar strengthened against major currencies as a Federal Reserve official hinted at no rush to cut rates amidst persistent inflation concerns. Japan's yen maintained its position against the ...
By close, the Sensex surged by 655.04 points or 0.90%, reaching 73,651.35, while the Nifty rose by 203.20 points or 0.92%, settling at 22,326.90. Among the listed stocks, 1912 registered gains, 1784 ...
Barbeque took ~2% price hike in some of the SKUs, since analysts of IIFL Securities previous survey. In the buffet section, prices have been similar vs their last survey.
Shashank Srivastava, the current head of the company's marketing and sales division, will join the executive committee on April 1.
Following the acquisition, Emami's shareholding in Brillare will increase from 95.36% to 100%, making Brillare a wholly-owned subsidiary of Emami Limited.
Unlike volume share, revenue share is much lower. This is because BSE is still charging much lower (Rs50 per mn of premium turnover) than the market leader; only in November’23, BSE increased tariff ...
Despite getting four observations from the United States Food and Drug Administration (USFDA), Zydus Lifesciences' share price increased to new 52-week high in afternoon trading session on March 28.